Postcovid syndrome — polymorphism of disorders in a new coronavirus infection-Reference-Cited by-同舟云学术

Postcovid syndrome — polymorphism of disorders in a new coronavirus infection

Published:2022-01-28 Issue:4 Volume:13 Page:7-20
ISSN:2077-9828
Container-title:HIV Infection and Immunosuppressive Disorders
language:
Short-container-title:VIČ-infekc. immunosupr.

Author:

Belyakov N. A.¹^ORCID,Trofimova T. N.²^ORCID,Rassokhin V. V.¹^ORCID,Rybakova M. G.³,Vasiliev B. B.⁴

Affiliation:

1. The first St. Petersburg State Medical University named after Academician I. P. Pavlov; Institute of Experimental Medicine; St.-Petersburg Research Institute of Epidemiology and Microbiology named after Pasteur

2. The first St. Petersburg State Medical University named after Academician I. P. Pavlov; Institute of Experimental Medicine

3. The first St. Petersburg State Medical University named after Academician I. P. Pavlov

4. Institute of Experimental Medicine

Abstract

COVID-19, having not completed its epidemic development, gradually passes into the stage of prolonged diseases, which at the clinical level is designated as «postcovid syndrome». The symptomatology of these negative phenomena is quite diverse, covers the dysfunction of many organs and systems, and deserves the formulation of polymorphism of secondary and delayed complications. They are based on the consequences of the transferred acute phase of inflammation, systemic prolonged metabolic and structural disorders, including the studied genetic disorders. Possible causes of polymorphism of disorders and their manifestations in the postcovid period are considered.

Publisher

Baltic Medical Education Center

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology

Reference66 articles.

1. Greenhalgh T., Knight M., A’Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care // Brit. Med. J. 2020. Vol. 370. m3026.

2. Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline // Brit. Med. J. 2021. Vol. 372. n136.

3. COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline [NG188] Published date: 18 December 2020] (англ.). NICE https://www.nice.org.uk/guidance/ng188.

4. Lu R. et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding // Lancet. 2020. Vol. 395. Р. 565–574.

5. Hu B., Guo H., Zhou P., Shi Z.-L. Characteristics of SARS-CoV-2 and COVID-19 // Nat. Rev. Microbiol. 2021. Vol. 19. Р. 141–154.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplex analysis of post-Covid cardiorenal complications in patients with type 1 and type 2 diabetes mellitus according to the mobile diagnostic and treatment center (Diamobil);Problems of Endocrinology;2024-01-24

2. Delayed mental, neurological and somatic disorders associated with COVID-19;HIV Infection and Immunosuppressive Disorders;2024-01-17

3. Postcovid necrosis of the cranio-maxillofacial region;Kazan medical journal;2023-07-24

4. The impact of the new coronavirus infection COVID-19 on the microcirculation of the eye;Russian Ophthalmological Journal;2023-07-02

5. Metabolic effects of non-drug therapy of post-Covid syndrome;Fizioterapevt (Physiotherapist);2023-01-21